Redeye: Formpipe - Positive outlook – low Licenses hurting EBIT in Q3

Report this content

We lower our sales forecast by 1% and increases our OPEX estimate by 1% for 2020, resulting in a quite sharp cut of 12% at the EBIT level. Formpipe has increased its OPEX slightly, investing in product development. This, combined with management’s positive outlook, will likely result in higher sales growth. However, as we assume that the SaaS share will continue to increase, we believe any substantial revenue gains will occur in 2021 and beyond. We leave our Base case at SEK 18.

Read more in the research update:

Start following companies at Redeye to instantly receive our latest equity research.

This is a press release from Redeye - Research Powered Investment Banking.